Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use.

ACS Omega · 2020 · PMC7745443 · PMID 33344861

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

possibly significantno p-value reported

13 With a short duration of action and possibly significant 5-HT 1A receptor selectivity, 5-MeO-DMT possesses unique pharmacodynamic and pharmacokinetic properties compared to other clinically studied psychedelics.

also in 649 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.